Sonoma Biotherapeutics
Seonhwa Dura is a seasoned professional in the field of biology, currently working as a Sr. Associate Scientist at Sonoma Biotherapeutics. With previous experience at Astellas Pharma US, Precision BioSciences, Inc., and BASF, Dura has held roles ranging from Principal Research Associate to Assistant Scientist. With a Master of Science degree in Biology from Texas A&M University, Dura also served as a Research Specialist II at The Institute for Advanced Learning and Research from 2007 to 2013.
This person is not in the org chart
This person is not in any offices
Sonoma Biotherapeutics
1 followers
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.